The efficacy and safety of collagenase clostridium histolyticum in the treatment of patients with moderate Dupuytren’s contracture

Author： McGrouther Duncan A.   Jenkins Aaron   Brown Stephanie   Gerber Robert A.   Szczypa Piotr   Cohen Brian  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.30, Iss.4, 2014-04, pp. : 733-739

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

CCH Phase 3 Open‐Label Study

By  

THE JOURNAL OF SEXUAL MEDICINE, Vol. 12, Iss. 1, 2015-01 ,pp. : 248-258

John Wiley & Sons Inc

Access to resources Recommend Favorite

The History of Collagenase Clostridium Histolyticum

By  

SEXUAL MEDICINE REVIEWS, Vol. 3, Iss. 4, 2015-10 ,pp. : 289-297

John Wiley & Sons Inc

Access to resources Recommend Favorite

PD Surgery Following CCH

By  

THE JOURNAL OF SEXUAL MEDICINE, Vol. 12, Iss. 1, 2015-01 ,pp. : 259-264

John Wiley & Sons Inc

Access to resources Recommend Favorite

Collagenase Clostridium histolyticum for the Treatment of Peyronie's Disease: The Development of This Novel Pharmacologic Approach

By  

THE JOURNAL OF SEXUAL MEDICINE, Vol. 12, Iss. 6, 2015-06 ,pp. : 1481-1489

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double‐blind, randomized, placebo‐controlled, phase III studies

By  

BJU INTERNATIONAL, Vol. 116, Iss. 4, 2015-10 ,pp. : 650-656

John Wiley & Sons Inc

Access to resources Recommend Favorite